Nanotechnology in therapeutics : a focus on nanoparticles as a drug delivery system Review

Continuing improvement in the pharmacological and therapeutic properties of drugs is driving the revolution in novel drug delivery systems. In fact, a wide spectrum of therapeutic nanocarriers has been extensively investigated to address this emerging need. Accordingly, this article will review recent developments in the use of nanoparticles as drug delivery systems to treat a wide variety of diseases. Finally, we will introduce challenges and future nanotechnology strategies to overcome limitations in this field.

[1]  He Lian,et al.  Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. , 2011, International journal of pharmaceutics.

[2]  Chung-Yuan Mou,et al.  The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. , 2007, Biomaterials.

[3]  J. Pedraz,et al.  Micro and nano drug delivery systems in cancer therapyArticle , 2005 .

[4]  A. R. Kulkarni,et al.  Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Ulrik B Nielsen,et al.  Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  C. Hawker,et al.  Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules , 1990 .

[7]  Deng-Fwu Hwang,et al.  In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. , 2007, Environmental science & technology.

[8]  A. Prokop,et al.  Nanovehicular intracellular delivery systems. , 2008, Journal of pharmaceutical sciences.

[9]  R. Satchi‐Fainaro,et al.  Polymer therapeutics for cancer : Current status and future challenges , 2006 .

[10]  S. P. Vyas,et al.  Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization. , 2001, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[11]  Thommey P. Thomas,et al.  Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy. , 2004, Bioconjugate chemistry.

[12]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[13]  P. Sabbatini,et al.  Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  C. Brazel,et al.  Synthesis and characterization of grafted thermosensitive hydrogels for heating activated controlled release. , 2007, International journal of pharmaceutics.

[15]  Samir Mitragotri,et al.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Lisbeth Illum,et al.  Long circulating microparticulate drug carriers , 1995 .

[17]  Victor S-Y Lin,et al.  Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. , 2007, Journal of the American Chemical Society.

[18]  V. Torchilin.  Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[19]  Richard B Greenwald,et al.  Effective drug delivery by PEGylated drug conjugates. , 2003, Advanced drug delivery reviews.

[20]  G Blume,et al.  Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.

[21]  Hans P. Merkle,et al.  Phagocytosis and Phagosomal Fate of Surface-Modified Microparticles in Dendritic Cells and Macrophages , 2003, Pharmaceutical Research.

[22]  P. Midgley,et al.  Uptake of C60 by human monocyte macrophages, its localization and implications for toxicity: studied by high resolution electron microscopy and electron tomography. , 2006, Acta biomaterialia.

[23]  S. Sahoo,et al.  Nanotech approaches to drug delivery and imaging. , 2003, Drug discovery today.

[24]  R K Jain,et al.  Barriers to drug delivery in solid tumors. , 1994, Scientific American.

[25]  S. Pramod,et al.  Carbon Nanotubes in Pharmaceutical Nanotechnology: An introduction to Future Drug Delivery System , 2013 .

[26]  Sung Ju Cho,et al.  Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells , 2007, Journal of nanobiotechnology.

[27]  E. Zubarev,et al.  Paclitaxel-functionalized gold nanoparticles. , 2007, Journal of the American Chemical Society.

[28]  Samuel Zalipsky,et al.  In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[29]  Y. Barenholz,et al.  Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. , 1989, European journal of cancer & clinical oncology.

[30]  Umesh Gupta,et al.  A review of in vitro-in vivo investigations on dendrimers: the novel nanoscopic drug carriers. , 2006, Nanomedicine : nanotechnology, biology, and medicine.

[31]  Jianjun Cheng,et al.  Drug-Initiated, Controlled Ring-Opening Polymerization for the Synthesis of Polymer-Drug Conjugates. , 2012, Macromolecules.

[32]  M. Yatvin,et al.  pH-sensitive liposomes: possible clinical implications. , 1980, Science.

[33]  Weihong Tan,et al.  DNA aptamer–micelle as an efficient detection/delivery vehicle toward cancer cells , 2009, Proceedings of the National Academy of Sciences.

[34]  Elaine Merisko-Liversidge,et al.  Nanosizing: a formulation approach for poorly-water-soluble compounds. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[35]  S. Nguyen,et al.  Polymer-caged lipsomes: a pH-responsive delivery system with high stability. , 2007, Journal of the American Chemical Society.

[36]  D Gan,et al.  Tunable swelling kinetics in core--shell hydrogel nanoparticles. , 2001, Journal of the American Chemical Society.

[37]  E. Oberdörster.  Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile Largemouth Bass , 2004, Environmental health perspectives.

[38]  Fabio Cerignoli,et al.  Quantum dot-doped silica nanoparticles as probes for targeting of T-lymphocytes , 2007, International journal of nanomedicine.

[39]  N. B. Graham,et al.  Nanogels and microgels: The new polymeric materials playground , 1998 .

[40]  L. Recht,et al.  A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[41]  D. Ding,et al.  Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system. , 2011, ACS nano.

[42]  Rainer H Müller,et al.  Nanocrystal technology, drug delivery and clinical applications , 2008, International journal of nanomedicine.

[43]  Indrajit Roy,et al.  Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. , 2007, Nano letters.

[44]  Norio Tada,et al.  A novel magnetic crystal-lipid nanostructure for magnetically guided in vivo gene delivery. , 2009, Nature nanotechnology.

[45]  M. Bergeron,et al.  Treatment of Visceral Leishmaniasis with Sterically Stabilized Liposomes Containing Camptothecin , 2001, Antimicrobial Agents and Chemotherapy.

[46]  Kenneth K. Chan,et al.  Phase I and pharmacologie study of liposomal daunorubicin (DaunoXome) , 2004, Investigational New Drugs.

[47]  F. Szoka,et al.  Chemical approaches to triggerable lipid vesicles for drug and gene delivery. , 2003, Accounts of chemical research.

[48]  W. Oyen,et al.  Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. , 2001, The Journal of pharmacology and experimental therapeutics.

[49]  F. Torti,et al.  The use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi's sarcoma patients treated with pegylated liposomal doxorubicin. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[50]  Wolfgang J Parak,et al.  Laser-induced release of encapsulated materials inside living cells. , 2006, Angewandte Chemie.

[51]  B. Říhová,et al.  Clinical implications of N-(2-hydroxypropyl)methacrylamide copolymers. , 2003, Current pharmaceutical biotechnology.

[52]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[53]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[54]  G. Hughes,et al.  Nanostructure-mediated drug delivery. , 2005, Disease-a-month : DM.

[55]  Zonghuan Lu,et al.  Magnetic switch of permeability for polyelectrolyte microcapsules embedded with Co@Au nanoparticles. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[56]  M. Dobrovolskaia,et al.  Immunological properties of engineered nanomaterials , 2007, Nature Nanotechnology.

[57]  B. Badie,et al.  Internalization of MWCNTs by microglia: Possible application in immunotherapy of brain tumors , 2007, NeuroImage.

[58]  H. Ringsdorf,et al.  Polymeric Antitumor Agents on a Molecular and on a Cellular Level , 1981 .

[59]  M. Radomski,et al.  Nanoparticles: pharmacological and toxicological significance , 2007, British journal of pharmacology.

[60]  Mauro Ferrari,et al.  Nanomedicine—Challenge and Perspectives , 2009 .

[61]  A. Krueger.  New Carbon Materials: Biological Applications of Functionalized Nanodiamond Materials , 2008 .

[62]  Yao Sun,et al.  Mesoscopic simulations on the aggregation behavior of pH-responsive polymeric micelles for drug delivery. , 2011, Journal of colloid and interface science.

[63]  Tim Liedl,et al.  Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. , 2005, Nano letters.

[64]  Ruth Duncan,et al.  Polymer conjugates as anticancer nanomedicines , 2006, Nature Reviews Cancer.

[65]  M. Keating,et al.  Clinical pharmacology of polyethylene glycol-L-asparaginase. , 1986, Drug metabolism and disposition: the biological fate of chemicals.

[66]  S. Manna,et al.  Single-Walled Carbon Nanotube Induces Oxidative Stress and Activates Nuclear Transcription Factor-κB in Human Keratinocytes , 2005 .

[67]  O. Rosen,et al.  Pegylated asparaginase in combination with high‐dose methotrexate for consolidation in adult acute lymphoblastic leukaemia in first remission: a pilot study , 2003, British journal of haematology.

[68]  Y. Barenholz,et al.  Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. , 1993, Biochimica et biophysica acta.

[69]  Shuming Nie,et al.  Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery , 2006, Molecular Cancer Therapeutics.

[70]  A. D'emanuele,et al.  In vitro evaluation of dendrimer prodrugs for oral drug delivery. , 2007, International journal of pharmaceutics.

[71]  Vincent M Rotello,et al.  Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles. , 2006, Angewandte Chemie.

[72]  E. Rivera.  Current status of liposomal anthracycline therapy in metastatic breast cancer. , 2003, Clinical breast cancer.

[73]  W. Zauner,et al.  In vitro uptake of polystyrene microspheres: effect of particle size, cell line and cell density. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[74]  F. Gao,et al.  Effects of antisense-myc-conjugated single-walled carbon nanotubes on HL-60 cells. , 2007, Journal of nanoscience and nanotechnology.

[75]  Donald A Tomalia,et al.  Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.

[76]  N. Shibata,et al.  Liquid filled nanoparticles as a drug delivery tool for protein therapeutics. , 2005, Biomaterials.

[77]  R. Zhuo,et al.  Reduction-responsive polymeric micelles for anticancer drug delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[78]  Xianglong Hu,et al.  Mixed polymeric micelles as multifunctional scaffold for combined magnetic resonance imaging contrast enhancement and targeted chemotherapeutic drug delivery , 2012 .

[79]  H. Tajmir-Riahi,et al.  Interaction of taxol with human serum albumin. , 2000, Biochimica et biophysica acta.

[80]  J. Schellens,et al.  Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel , 2001, Anti-cancer drugs.

[81]  Z. Tökés,et al.  In vitro and in vivo studies with adriamycin liposomes. , 1979, Biochemical and biophysical research communications.

[82]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[83]  Warren C W Chan,et al.  Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.

[84]  Yanyu Xiao,et al.  Octreotide-modified and pH-triggering polymeric micelles loaded with doxorubicin for tumor targeting delivery. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[85]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[86]  Marc D. Porter,et al.  Alkanethiolate Gold Cluster Molecules with Core Diameters from 1.5 to 5.2 nm: Core and Monolayer Properties as a Function of Core Size , 1998 .

[87]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Rona Chandrawati,et al.  A microreactor with thousands of subcompartments: enzyme-loaded liposomes within polymer capsules. , 2009, Angewandte Chemie.

[89]  H. Ghandehari,et al.  Extravasation of Poly(amidoamine) (pamam) Dendrimers Across Microvascular Network Endothelium , 2004, Pharmaceutical Research.

[90]  Zhi Zhu,et al.  Photoresponsive DNA-cross-linked hydrogels for controllable release and cancer therapy. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[91]  H. Ringsdorf.  Structure and properties of pharmacologically active polymers , 1975 .

[92]  Scott J Hollister,et al.  Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[93]  D. Mcilroy,et al.  Differential cytotoxicity exhibited by silica nanowires and nanoparticles , 2008 .

[94]  Jon Dobson,et al.  Magnetic micro- and nano-particle-based targeting for drug and gene delivery. , 2006, Nanomedicine.

[95]  Guilin Wang,et al.  Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. , 2008, Expert opinion on drug delivery.

[96]  S. Groshen,et al.  Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

[97]  P. Gupta,et al.  Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.

[98]  Andreas M. Nyström,et al.  Linear-Dendritic Polymeric Amphiphiles as Carriers of Doxorubicin-In Vitro Evaluation of Biocompatibility and Drug Delivery , 2012 .

[99]  D. S. Lee,et al.  Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers. , 2012, International journal of pharmaceutics.

[100]  W. Gradishar,et al.  Albumin-bound paclitaxel: a next-generation taxane , 2006, Expert opinion on pharmacotherapy.

[101]  C. Chen,et al.  Preparation and properties of thermoreversible hydrogels based on methoxy poly(ethylene glycol)-grafted chitosan nanoparticles for drug delivery systems , 2011 .

[102]  J. Reddy,et al.  Folate-targeted chemotherapy. , 2004, Advanced drug delivery reviews.

[103]  Hassan S. Bazzi,et al.  Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots , 2005, Journal of Molecular Medicine.

[104]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[105]  Indrajit Roy,et al.  New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug. , 2007, Molecular pharmaceutics.

[106]  Tae-You Kim,et al.  Phase I and Pharmacokinetic Study of Genexol-PM, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients with Advanced Malignancies , 2004, Clinical Cancer Research.

[107]  S. Croft,et al.  Liposomal amphotericin B in drug-resistant visceral leishmaniasis , 1991, The Lancet.

[108]  Rebecca Richards-Kortum,et al.  Optical molecular imaging agents for cancer diagnostics and therapeutics. , 2006, Nanomedicine.

[109]  M. Bally,et al.  The liposomal formulation of doxorubicin. , 2005, Methods in enzymology.

[110]  Hua Ai,et al.  Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. , 2006, Nano letters.

[111]  F. M. Gama,et al.  Development of a hybrid dextrin hydrogel encapsulating dextrin nanogel as protein delivery system. , 2012, Biomacromolecules.

[112]  Shiladitya Sengupta,et al.  Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system , 2005, Nature.

[113]  W. E. Billups,et al.  Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. , 2006, Toxicology letters.

[114]  M. Prato,et al.  Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. , 2006, Nano letters.

[115]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[116]  M. Grinstaff,et al.  Hydrogels as intracellular depots for drug delivery. , 2012, Molecular pharmaceutics.

[117]  Zahi A. Fayad,et al.  Perspectives and opportunities for nanomedicine in the management of atherosclerosis , 2011, Nature Reviews Drug Discovery.

[118]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[119]  R. Langer,et al.  Nanomedicine: developing smarter therapeutic and diagnostic modalities. , 2006, Advanced drug delivery reviews.

[120]  J. Zhang,et al.  Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[121]  J. Singer,et al.  Synthesis and in Vivo Antitumor Activity of Poly(l-glutamic acid) Conjugates of 20(S)-Camptothecin , 2003 .

[122]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[123]  Hung-Ting Chen,et al.  Synthesis and functionalization of a mesoporous silica nanoparticle based on the sol-gel process and applications in controlled release. , 2007, Accounts of chemical research.

[124]  Juan L. Vivero-Escoto,et al.  Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.

[125]  Takuro Niidome,et al.  PEG-modified gold nanorods with a stealth character for in vivo applications. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[126]  Swarnlata Saraf,et al.  Nanocarriers: promising vehicle for bioactive drugs. , 2006, Biological & pharmaceutical bulletin.

[127]  J. Baker,et al.  Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo , 2010, Anti-cancer drugs.

[128]  Christopher G Thanos,et al.  The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. , 2006, Biomolecular engineering.

[129]  P. Baron,et al.  Exposure to Carbon Nanotube Material: Assessment of Nanotube Cytotoxicity using Human Keratinocyte Cells , 2003, Journal of toxicology and environmental health. Part A.

[130]  M. Prato,et al.  Carbon nanotubes as nanomedicines: from toxicology to pharmacology. , 2006, Advanced drug delivery reviews.

[131]  V. Rotello,et al.  Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. , 2006, Journal of the American Chemical Society.

[132]  Mark H Schoenfisch,et al.  Water-soluble nitric oxide-releasing gold nanoparticles. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[133]  M J Hawkins,et al.  Abraxane, a novel Cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[134]  M. Grinstaff,et al.  Therapeutic and diagnostic applications of dendrimers for cancer treatment. , 2008, Advanced drug delivery reviews.

[135]  Kazunori Kataoka,et al.  Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. , 2006, Pharmacology & therapeutics.

[136]  J. F. Stoddart,et al.  Mesostructured Silica Supports for Functional Materials and Molecular Machines , 2007 .

[137]  M Sugisaka,et al.  Nanotechnology on duty in medical applications. , 2005, Current pharmaceutical biotechnology.

[138]  Ana B. Descalzo,et al.  The supramolecular chemistry of organic-inorganic hybrid materials. , 2006, Angewandte Chemie.

[139]  J. James,et al.  A Review of Carbon Nanotube Toxicity and Assessment of Potential Occupational and Environmental Health Risks , 2006, Critical reviews in toxicology.

[140]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[141]  B. R. Steele,et al.  New drug delivery nanosystem combining liposomal and dendrimeric technology (liposomal locked-in dendrimers) for cancer therapy. , 2010, Journal of pharmaceutical sciences.

[142]  Yan Xiao,et al.  Self-assembly of pH-sensitive mixed micelles based on linear and star copolymers for drug delivery. , 2011, Journal of colloid and interface science.

[143]  K. Ulbrich,et al.  Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[144]  E. Ruoslahti,et al.  Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.

[145]  L. Hegedũs,et al.  High affinity binding of paclitaxel to human serum albumin. , 2001, European journal of biochemistry.

[146]  H. Ringsdorf,et al.  Molecular Architecture and Function of Polymeric Oriented Systems: Models for the Study of Organization, Surface Recognition, and Dynamics of Biomembranes , 1988 .

[147]  R. J. Lee,et al.  Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.

[148]  J E Kipp,et al.  The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. , 2004, International journal of pharmaceutics.

[149]  R. Boulieu,et al.  Effect of polyethylene glycol-modified adenosine deaminase (PEG-ADA) therapy in two ADA-deficient children: measurement of erythrocyte deoxyadenosine triphosphate as a useful tool. , 1991, Advances in experimental medicine and biology.

[150]  Volker Wagner,et al.  The emerging nanomedicine landscape , 2006, Nature Biotechnology.

[151]  S. Al-suwayeh,et al.  Treatment of experimental osteomyelitis by liposomal antibiotics. , 2004, The Journal of antimicrobial chemotherapy.

[152]  H. Dureja,et al.  Nanoparticle technology for the delivery of poorly water-soluble drugs , 2006 .

[153]  U. Schubert,et al.  Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. , 2010, Angewandte Chemie.

[154]  Jianzhong Wu,et al.  Phase behavior of thermally responsive microgel colloids. , 2003, Physical review letters.

[155]  R. Barbucci,et al.  A novel strategy for engineering hydrogels with ferromagnetic nanoparticles as crosslinkers of the polymer chains. Potential applications as a targeted drug delivery system , 2011 .

[156]  Neil Desai,et al.  Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[157]  Xiaojun Cao,et al.  A NEW CONVERGENT APPROACH TO DENDRITIC MACROMOLECULES , 2002 .

[158]  Mehrdad Hamidi,et al.  Hydrogel nanoparticles in drug delivery. , 2008, Advanced drug delivery reviews.

[159]  Shuming Nie,et al.  Bioconjugated quantum dots for in vivo molecular and cellular imaging. , 2008, Advanced drug delivery reviews.

[160]  S. Slack,et al.  Particle diameter influences adhesion under flow. , 2001, Biophysical journal.

[161]  Xiaoling Zhang,et al.  Near-infrared light-responsive core-shell nanogels for targeted drug delivery. , 2011, ACS nano.

[162]  H. Ohshima,et al.  Dependence of the phagocytic uptake of polystyrene microspheres by differentiated HL60 upon the size and surface properties of the microspheres , 2002 .

[163]  Patrick Soon-Shiong,et al.  Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[164]  W. D. de Jong,et al.  Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.

[165]  A. D'emanuele,et al.  Crossing cellular barriers using dendrimer nanotechnologies. , 2006, Current opinion in pharmacology.

[166]  G. Levi,et al.  Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system , 1998, Gene Therapy.

[167]  J. James,et al.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[168]  J. Pinto,et al.  Synthesis of Biodegradable Hydrogel Nanoparticles for Bioapplications Using Inverse Miniemulsion RAFT Polymerization , 2011 .

[169]  Andre G. Skirtach,et al.  Stimuli-sensitive nanotechnology for drug delivery , 2009 .

[170]  Chung-Yuan Mou,et al.  Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. , 2009, Small.

[171]  L. Murray,et al.  Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[172]  Zhuang Liu,et al.  Drug delivery with carbon nanotubes for in vivo cancer treatment. , 2008, Cancer research.

[173]  V. Mohanraj,et al.  Nanoparticles - A Review , 2007 .

[174]  L. Forró,et al.  Cellular toxicity of carbon-based nanomaterials. , 2006, Nano letters.

[175]  Eric Pridgen,et al.  Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.

[176]  H. Pelicano,et al.  Glycolysis inhibition for anticancer treatment , 2006, Oncogene.

[177]  A. Kabanov,et al.  Anthracycline antibiotics non-covalently incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. , 1996, British Journal of Cancer.

[178]  Baowei Fei,et al.  Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. , 2008, Journal of the American Chemical Society.

[179]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[180]  L. Thrall.  Study links TiO2 nanoparticles with potential for brain-cell damage. , 2006, Environmental science & technology.

[181]  P. Glue,et al.  A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group. , 2000, Hepatology.

[182]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[183]  P. Chu,et al.  Magnetite-loaded fluorine-containing polymeric micelles for magnetic resonance imaging and drug delivery. , 2012, Biomaterials.

[184]  Naveed Ahmad,et al.  Synthesis and characterization of thermo- and pH-responsive bacterial cellulose/acrylic acid hydrogels for drug delivery , 2012 .

[185]  Samir Mitragotri,et al.  Designer Biomaterials for Nanomedicine , 2009 .

[186]  H. Shmeeda,et al.  Pros and Cons of the Liposome Platform in Cancer Drug Targeting , 2006, Journal of liposome research.

[187]  S. Manna,et al.  Single-walled carbon nanotube induces oxidative stress and activates nuclear transcription factor-kappaB in human keratinocytes. , 2005, Nano letters.

[188]  D. Mitchison,et al.  The early bactericidal activity of a low-clearance liposomal amikacin in pulmonary tuberculosis. , 2001, The Journal of antimicrobial chemotherapy.

[189]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[190]  T. Okano,et al.  Development of the polymer micelle carrier system for doxorubicin. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[191]  Samir K. Gupta,et al.  A Dose‐Ranging Study of Pegylated Interferon Alfa‐2b and Ribavirin in Chronic Hepatitis C , 2000 .

[192]  J. Adler-Moore,et al.  AmBisome targeting to fungal infections. , 1994, Bone marrow transplantation.

[193]  Stephanie E. A. Gratton,et al.  The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.

[194]  Chong Cheng,et al.  pH-Sensitive brush polymer-drug conjugates by ring-opening metathesis copolymerization. , 2011, Chemical communications.

[195]  S. Cryan,et al.  Carrier-based strategies for targeting protein and peptide drugs to the lungs , 2005, The AAPS Journal.

[196]  Sanjiv S Gambhir,et al.  A pilot toxicology study of single-walled carbon nanotubes in a small sample of mice. , 2008, Nature nanotechnology.